Dermisonics, Inc. Share Price

Equities

DMSI

US24983U1043

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 09:46:09 18/04/2024 pm IST 5-day change 1st Jan Change
0.000025 USD +2,400.00% Intraday chart for Dermisonics, Inc. 0.00% +2,400.00%
Sales 2005 - Sales 2006 - Capitalization 15.69M 1.31B
Net income 2005 -6M -500M Net income 2006 -5M -417M EV / Sales 2005 -
Net Debt 2005 3.38M 282M Net Debt 2006 3M 250M EV / Sales 2006 -
P/E ratio 2005
-5.17 x
P/E ratio 2006
-2.94 x
Employees 1
Yield 2005 *
-
Yield 2006
-
Free-Float 70.26%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
0.00
3 years
0.00
Extreme 0
0.01
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
0.04
More quotes
Managers TitleAgeSince
President - -
Members of the board TitleAgeSince
President - -
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 18, 2024 at 09:46 pm IST

More quotes
Coded Growth Innovation Center, Inc., formerly Dermisonics, Inc., is a development stage company. The Company’s principal activity is to provide drugs delivery system. Its Transdermal systems deliver drugs through the skin into the bloodstream. Medications delivered via skin patches avoid liver metabolism, a necessary feature for drug molecules to metabolize easily, and allows for lower dosing of medications. There are two types of transdermal delivery systems: passive and active. In passive transdermal systems, the drug diffuses through the skin where it can act locally or penetrate the capillaries for systemic effect. Active patches require a physical force to facilitate the movement of drug molecules across the skin. It is a development stage company.
More about the company